每經(jing)AI快訊，1月24日，國家藥品(pin)(pin)監(jian)(jian)督管理局藥品(pin)(pin)審評中(zhong)(zhong)(zhong)心(xin)網站(zhan)(zhan)(zhan)消息(xi)(xi)(xi)，近日，我(wo)中(zhong)(zhong)(zhong)心(xin)收到(dao)有關(guan)媒(mei)體和(he)(he)企業反映，國家藥監(jian)(jian)局藥品(pin)(pin)審評中(zhong)(zhong)(zhong)心(xin)網站(zhan)(zhan)(zhan)對外公(gong)開的個別品(pin)(pin)種存在(zai)數據(ju)重(zhong)復的問(wen)題。我(wo)中(zhong)(zhong)(zhong)心(xin)高度(du)(du)重(zhong)視，立即對相關(guan)品(pin)(pin)種的數據(ju)進行了核實(shi)。經(jing)核實(shi)，系(xi)在(zai)2019年和(he)(he)2021年公(gong)開相關(guan)產(chan)品(pin)(pin)信息(xi)(xi)(xi)時，由于編輯錯誤導(dao)致上(shang)述問(wen)題。我(wo)中(zhong)(zhong)(zhong)心(xin)已第(di)一時間在(zai)中(zhong)(zhong)(zhong)心(xin)網站(zhan)(zhan)(zhan)對錯誤信息(xi)(xi)(xi)進行更正。對于工作中(zhong)(zhong)(zhong)出(chu)現的失(shi)誤，我(wo)中(zhong)(zhong)(zhong)心(xin)深表歉意。后續我(wo)中(zhong)(zhong)(zhong)心(xin)將加強公(gong)開信息(xi)(xi)(xi)的審核力(li)度(du)(du)，避免類似問(wen)題再次發生。歡迎社會各界監(jian)(jian)督！